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Background: parent-of-origin effects (POE) play important roles in complex disease and thus understanding
their regulation and associated molecular and phenotypic variation are warranted. Previous studies mainly
focused on the detection of genomic regions or phenotypes regulated by POE. Understanding whether POE
may be modified by environmental or genetic exposures is important for understanding of the source of
POE-associated variation, but only a few case studies addressing modifiable POE exist.
Methods: in order to understand this high order of POE regulation, we screened 101 genetic and environmen-
tal factors such as ‘predicted mRNA expression levels’ of DNA methylation/imprinting machinery genes and
environmental exposures. POE-mQTL-modifier interaction models were proposed to test the potential of
these factors to modify POE at DNA methylation using data from Generation Scotland: The Scottish Family
Health Study(N=2315).
Findings: a set of vulnerable/modifiable POE-CpGs were identified (modifiable-POE-regulated CpGs, N=3).
Four factors, ‘lifetime smoking status’ and ‘predicted mRNA expression levels’ of TET2, SIRT1 and KDM1A,
were found to significantly modify the POE on the three CpGs in both discovery and replication datasets. We
further identified plasma protein and health-related phenotypes associated with the methylation level of
one of the identified CpGs.
Interpretation: the modifiable POE identified here revealed an important yet indirect path through which
genetic background and environmental exposures introduce their effect on DNA methylation, motivating
future comprehensive evaluation of the role of these modifiers in complex diseases.
Funding: NSFC (81971270),H2020-MSCA-ITN(721815), Wellcome (204979/Z/16/Z,104036/Z/14/Z), MRC
(MC_UU_00007/10, MC_PC_U127592696), CSO (CZD/16/6,CZB/4/276, CZB/4/710), SFC (HR03006), EURO-
SPAN (LSHG-CT-2006-018947), BBSRC (BBS/E/D/30002276), SYSU, Arthritis Research UK, NHLBI, NIH.









B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)1. Introduction
Illustrating the sources of variation in DNA methylation lays the
foundation for understanding epigenetic-based biomarkers for
Research in context
Evidence before this study
Previous population studies showed that parent-origin-effects
(POE) on human methylome can be widespread and affect
health-related traits and diseases. Whether the POE remain sta-
ble throughout the life or can be modified by genetic or envi-
ronmental factors was largely unknown. The POE are mainly
introduced by imprinting. A case study reported one imprinted
locus where the imprinting status was modified by genetic var-
iants and environmental factors such as maternal nutrition and
maternal age, and that the modulated imprinting status influ-
enced childhood BMI. Whether the POE at DNA methylation
levels could be modified and which genetic/environmental fac-
tor could introduce this POE-specific modification effect
remained unknown.
Added value of this study
By systematically screening 101 genetic and environmental fac-
tors in a large cohort(GS:SFHS) we provided population-level
replicated evidence that those measuring lifestyle (smoking)
and predicted expression of DNA methylation- or imprinting-
machinery genes are amongst the factors that can modulate the
POE of mQTLs for a set of CpG sites. We found those modifi-
able-POE-regulated CpGs are also phenotypically relevant
one is associated with the plasma levels of CLEC4C and
health-related phenotypes such as HDL levels.
Implications of all the available evidence
The modifiable POE identified here revealed an important yet
indirect path through which genetic background and environ-
mental exposures introduce their effect on DNA methylation
and their associated phenotypes. This also provided a paradigm
for further studies to explore how environmental and genetic
effects can be integrated at methylation level.
2 Y. Zeng et al. / EBioMedicine 74 (2021) 103730disease risk and progress prediction [1,2]. DNA methylation is known
to be influenced by additive and non-additive genetic and environ-
mental factors [3-5]. As a special form of non-additive genetic effects,
parent-of-origin effects (POE) on the human methylome manifest as
differences in methylation levels between the reciprocal heterozygotes
of the mQTL depending on the allelic parent-of-origin (Figure 1) [6].
Through selectively silencing the maternal or paternal allele, genomic
imprinting has been considered as the major driving force creating the
POE phenomenon [6]. We and others have shown that POE-influenced
methylation sites are not rare, many are regulated by mQTLs, and that
they follow one of the three classical imprinting patterns: parental, bipo-
lar dominance and polar dominance (Figure 1) [4,7,8]. Although they
only comprise a small proportion of the genome, POE (imprinting)-regu-
lated CpGs and genes have been found to be important for developmen-
tal, metabolic and behavioral traits [4,9].
Despite their functional importance, the POE patterns in those
POE (imprinting)-influenced regions can fluctuate as a consequence
of genetic and environmental variation. Previous studies have
reported that a large fraction of imprinted regions deviated from
mono-allelic expression and that birth phenotypes were associated
with the extent of this deviation [10]. A case study on an imprinting
influenced long non-coding RNA, lncRNA nc886, found that the
imprinting status of this locus is tunable by both genetic variants and
environmental factors such as maternal nutrition and maternal age
[11]. Importantly, the altered POE has phenotypic consequences: loss
of imprinting of nc886 in infants at birth resulted in increased bodymass index (BMI) in childhood [11]. For the majority of other POE-
influenced regions, however, whether POE are modifiable under cer-
tain conditions remains unknown. Here we aim to explore modifiable
POE, manifesting as the altered methylation difference between
reciprocal heterozygotes of the mQTL due to effects from certain
genetic or environmental modifiers (Figure 1), which potentially rep-
resents an important layer of POE-related regulation requiring sys-
tematic examination.
To search for modifiable POE on CpGs, a key question is which
modifiers may have the potential to regulate the POE. Genomic
imprinting, which likely underlies the POE, involves complex and
multi-stage DNA methylation reprogramming processes, from the
slow erasure of methylation at primordial germ cell stage, to the
establishment of imprinted methylation signatures at germ cell stage,
followed by pre-implantation maintenance of the imprinted methyl-
ation pattern during the global demethylation event, which is subse-
quently maintained post-implantation [12]. A number of gametic and
zygotic genetic factors were found to be involved in these processes,
such as those functioning in folate metabolism, the DNA methylation
machinery (writers, erasers) and the proteins with which they inter-
act [12]. Additionally, imprinting-related processes have also been
found to be sensitive to environmental insults, such as the stress
induced by assisted reproductive technologies, nutritional deficiency
and adverse exposures [12-14]. Given that previous studies of modi-
fiers of genomic imprinting were mostly case studies of individual
factors, a systematic and population-wide scanning for genetic and
environmental modifiers of POE is essential to fully characterize POE
regulation.
In this study, we used Generation Scotland: The Scottish Family
Health Study (GS:SFHS), a large family-based population cohort with
extensive environmental and phenotypic records [15,16], genome-
wide genotypes and DNA methylation data [17,18], to identify
genetic and environmental factors that modify the POE on the human
methylome (Figure 1). Figure 2 illustrates the study design. Based on
the 2372 previously identified independent mQTL-CpGs pairs con-
taining mQTLs with parent-of-origin effect (1895 independent
mQTLs; 381211 SNPs in total) and their regulated CpGs (399 inde-
pendent CpGs; 586 CpGs in total) [4], we proposed an interaction
model which tests for significant interaction effects (Figure 1)
between each of the 101 candidate environmental/genetic modifiers
available in GS:SFHS and the parent-of-origin effect of each mQTL on
the corresponding targeted CpG. Significant results from discovery
samples (GS:SFHS set1, N=1663) were tested in replication samples
(GS:SFHS set2, N=652). After modifiable-POE-regulated CpGs were
identified, we further characterized those CpGs by examining their
associations with potentially important plasma proteins measured by
Olink panels (designed to capture proteins relevant to diseases and
important biological processes) and associations with other health-
related phenotypes to evaluate the phenotypic relevance for this spe-
cial class of CpGs.
2. Methods
2.1. Ethics
GS:SFHS study was ethically approved by the Tayside Research
Ethics Committee (reference 05/S1401/89). Participants all gave writ-
ten consent after having an opportunity to discuss the research and
before any data or samples were collected. ORCADES study received
ethical approval from the appropriate research ethics committees in
2004. Informed consent was provided by all participants.
2.2. Population samples
GS:SFHS is a deeply phenotyped family-based population cohort
with genome-wide genotypes available for 19994 participants
Figure 1. Patterns of classical and modifiable parent-of-origin effect (POE) regulation on DNA methylation. X axis: mQTL genotypes, left purple: paternal allele, right pink: maternal
allele. Y axis: methylation level of the regulated CpG. Upper panel: classical POE patterns including parental and complex (dominance) POE patterns. Parental patterns show two
levels of methylation depending on the expressed allele and the allelic effect. Complex POE manifests as the two homozygous groups having the same methylation level whereas
the heterozygous groups are different. Dashed box: difference between methylation level of heterozygous groups of the mQTL is the hallmark of POE. Bottom: scenarios when the
POE is modified by genetic or environmental factors, leading to the alteration of POE for different levels of the modifier.
Y. Zeng et al. / EBioMedicine 74 (2021) 103730 3[15,16]. Participants were recruited from the registers of collaborat-
ing general practices in Scotland between 2006 and 2011. At least
one first-degree relative aged 18 or over was required to be identified
for each participant [15,16]. Among GS:SFHS participants, 9526/
19994 have DNA methylation data in blood available(see below),
7106/19994 have the parent-of-origin allelic inheritance of all
imputed common SNPs successfully inferred with high accuracy
[4,15,17,18]. This lead to a total of 2315 GS:SFHS participants with
both DNA methylation and parent-of-origin phased genotypes avail-
able, which allowed analyses to identify CpGs regulated by modifi-
able POE here. We categorized those 2315 participants into two
groups, according to their collection batches for DNA methylation
data. We used those from the first batch as the discovery dataset
(N=1663), and those from the second batch as the replication dataset
(N=652). We additionally make full use of all 9526 participants with
methylation data and the collection of phenotype information avail-
able in GS:SFHS to explore health-related phenotypes associated
with modifiable-POE-regulated CpGs.
ORCADES is a family-based cross-sectional study which recruited
2078 participants between 2005 and 2011 from the Orkney Isles in
northern Scotland [19]. Proteomic and DNA methylation data were
available for a subset of 940 participants and were used here for asso-
ciation test between modifiable-POE-regulated CpGs and plasma pro-
teins.
2.2.1. GS:SFHS cohort: genotypes and inference of parent-of-origin
transmission of alleles in offspring
Genome-wide genotypes were generated using the Illumina
Human OmniExpressExome -8- v1.0 array [20]. Phasing, imputation
and quality control were described previously [4,21]. In total,7108491 high-quality imputed common SNPs (MAF .01, info score
 0.8) for 19994 participants were available for subsequent analyses.
Among those individuals, there were 7139 offspring with at least one
of their parents genotyped in GS:SFHS, which allowed us to success-
fully infer parent-of-origin allelic inheritance of all imputed common
SNPs in 7106 offspring with high accuracy [4].
2.2.2. GS:SFHS cohort: DNA methylation
In GS:SFHS, genome-wide DNA methylation data were produced
through a related Stratifying Resilience and Depression Longitudi-
nally (STRADL) project [18]. In 2016, the first batch of methylation
data was generated on 5081 participants. These were used as discov-
ery subset. 1663 of these participants also had imputed genotype
information with parent-of-origin alleles successfully inferred and
were used for the scanning for modifiable POE here. In 2019, another
batch of methylation data was generated on an independent subset
of 4445 participants. These data were used as replication subset. 652
out of these 4445 participants had imputed genotype information
with parent-of-origin alleles successfully inferred. Based on a pipe-
line proposed previously [4], the two datasets were generated, proc-
essed and quality controlled in consistent way [22], which was
briefly described in Text s1.
2.2.3. GS:SFHS cohort: Environmental/genetic modification variables
Environmental modifier variables
Environments and life events can be important sources of modi-
fiers for POE [12-14]. The core GS:SFHS cohort has rich collections of
environmental variables [15]. Moreover, 98% of GS:SFHS participants
gave informed consent for data linkage with historic Scottish birth
cohorts which contain collections of birth and maternity information
Figure 2. Design of the study. Cov: covariates fitted in the model. Zeng et al.(2019): the study which reported CpGs regulated by POE and the mQTLs that induce the POE for 586
CpGs (reference 4).
4 Y. Zeng et al. / EBioMedicine 74 (2021) 103730(Text s2). In total, we were able to collect 75 environmental variables
and used them in downstream analyses. The variables ranged from
baseline variables (sex, age etc.), medication (blood pressure lower-
ing medication, antidepressants etc,), lifestyle (smoking, exposure to
smoking, alcohol consumption, diet, physical activity etc.), living/
socio-economic status (number of people sharing the house, job type,
parents’ health conditions etc.), birth-related phenotypes (birth
weight, gestational age, etc.) and menarche/menopause-related
events. A full list of environmental variables is given in Table s1.
2.2.4. Genetic modifier variables
Genetic factors that are involved in establishment and mainte-
nance of imprinting can be important sources of modifiers for POE
[12]. We considered two categories of genetic modifiers:
1) Predicted mRNA expression levels of 17 DNA methylation or
imprinting-specific machinery genes. DNA methylation or
imprinting-specific machinery genes play crucial roles in imprint-
ing [12]. Since GS:SFHS participants don’t have directly measured
mRNA expression levels and prediction model has been proven to
be effective in evaluating genetically-determined expression vari-
ation [23], PrediXcan was applied to impute gene expression lev-
els of machinery genes in blood [23]. A list of 30 genes was
collated from the literature on the basis of having critical roles inDNA methylation in general, such as methylation writers and
erasers, or in imprinting specifically (Table s2). Among them 17
have their mRNA expression levels in blood successfully predicted
(details in Text s2 and Table s1).
2) Nine genetic risk scores (PRSs) for folate metabolism. Folate and
one-carbon metabolism play important roles in DNA methylation
turnover and genomic imprinting [12]. Genetic variation can con-
tribute to individual variation in this pathway. PRSs were there-
fore created to represent a participant's genetic predisposition for
functions relating to folate metabolism (details in Text s2 and
Table s1.).
2.3. Statistics
2.3.1. POE-mQTL-modifier interaction models
We applied a POE-mQTL-interaction model to test whether envi-
ronmental or genetic factors could modify the POE induced by mQTL
on CpGs. The model built on a linear regression model that we used
to identify POE-specific mQTL-CpG pairs (mQTL with a parent-of-ori-
gin effect and the CpG it regulated) in our previous study [4,24]:
model 1 - non-interaction model:
Methylcpg ¼ AddmQTL þ DommQTL þ POEmQTL þ covariatesþ error
Y. Zeng et al. / EBioMedicine 74 (2021) 103730 5Where for the additive genetic variable (AddmQTL), the dominance
genetic variable (DommQTL) and the parent-of-origin effect (POEmQTL),
genotypes were coded as below:AA Aa aA aa
Additive 0 1 1 2
Dominance 0 1 1 0
Parent-of-origin 0 -1 1 0In this study, we applied an interaction model that additionally
includes a modifier variable, Mod, and its interaction with the addi-
tive genetic effect and the POE:
model2 - interaction model:
Methylcpg ¼ AddmQTL þ DommQTL þ POEmQTL þModþ AddmQTLxMod
þPOEmQTLxModþ covariatesþ error
Where the modifier variable (Mod) was one of the environmental/
genetic variables collected/derived as described in the section ‘GS:
SFHS cohort: Environmental/genetic modification variables’. Covari-
ates included age, sex, cell proportions, smoking variables (‘pack
years’ and ‘lifetime smoking status’, which were not included as cova-
riates when they were the tested modifier factor) and principal com-
ponents (PCs) derived from an OMIC-relationship-matrix (ORM)
created in OSCA [25] using all measured DNA methylation sites. To
avoid removing genetic signals of interest by fitting ORM-PCs, we
only included ORM-PCs among the top 20 ORM-PCs that were not
significantly associated with any common SNP(determined through
performing GWAS for ORM-PCs). We applied this model and tested
the significance of the interaction effect between each mQTL’s POE
and the modifier variable (POEmQTL x Mod, short for POEmQTL x Modi-
fier) on the corresponding CpG. Throughout the paper, we described
an interaction effect (POEmQTL x Mod) on a CpG as a mQTL-modifier-
CpG trio. The mQTL-CpG pairs tested were the 2372 independent
POE-specific mQTL-CpG pairs which we reported previously [4]. The
interaction between the additive effect and the modifier (AddmQTL x
Mod) was jointly fitted in the model. For simplicity we did not fit an
interaction between the dominance effect and the modifier (DommQTL
x Mod) in the global scan, but we did this in sensitivity tests for the
significant mQTL-modifier-CpG trios we identified. The results indi-
cated only a minor contribution of the DommQTL x Mod effect (Table
s3). Multiple testing correction was performed by a combination of a
global permutation test and mQTL-modifier-CpG trio-specific permu-
tation tests for POEmQTL x Modifier interaction effect at discovery stage
(FDR0.05, details see Text s3, Table s4). A successful replication
required to both reach statistical significance (FDR0.05) and patten
consistency (details in Text s3, Table s4-6). Visualization of the results
was performed using the R package coMET and ggplot2 [26,27].
2.3.2. Identification of proteins and mRNAs associated with CpGs
regulated by modifiable POE
ORCADES cohort- DNA methylation and proteomic data:
DNA methylation levels was measured from whole blood samples
using Illumina MethylationEPIC Array for 794627 CpG sites in 1052
samples (quality control and pre-correction in Text s4). Abundance of
plasma proteins was measured from the fasted EDTA plasma samples
for a subset of 1051 participants using Olink Proseek Multiplex cardi-
ometabolic, cell regulation, cardiovascular 2 and 3, developmental,
immune response, inflammation 1, metabolism, neuro exploratory,
neurology, oncology and organ damage panels. The raw NPX values
were used in analysis.
2.3.3. Association between DNA methylation and plasma protein levels
A linear mixed model was used to compute methylation residuals
after adjusting for genetic structure in ORCADES by fitting a random
effect represented in the genomic relationship matrix. To assess
whether the CpGs (Ncpg=3) significantly regulated by interaction
effects (POEmQTL x Mod) were associated with the abundance of anyplasma protein (Nprotein=1092), the association between adjusted
methylation of CpGs of interest with each measured protein was
tested using a linear regression model in 940 participants where DNA
methylation and proteomic data were simultaneously available:
Methyl ¼ proteinþ cell proportionþ ageþ sexþ season of sampling
þ smoking statusþ error
The Bonferroni method was applied to correct for multiple testing
(Ncorrection=3 £ 1092=3276).
2.3.4. Correlations between DNA methylation vs mRNA levels
Transcriptomic and DNAmethylation data from human peripheral
monocytes and T cells in the Multi-Ethnic Study of Atherosclerosis
(MESA) study were downloaded from the NCBI GEO database (Series
GSE56047 and GSE56580) [28]. mRNA was measured using the Illu-
mina HumanHT-12 v4 Expression BeadChip, DNA methylation levels
were measured using the Illumina HumanMethylation450 BeadChip
[28]. Quantile-normalized signal for mRNA (log2 transformed) and
DNA methylation data (M-values) were simultaneously available for
peripheral monocytes (CD14+) in 1202 participants and for periph-
eral T cells (CD4+) in 214 participants and were used to calculate the
Spearman correlation between DNA methylation and mRNA.
2.3.5. Correlations between mRNAs levels
At the population-level, correlations between mRNA levels of tar-
get genes were calculated using the Spearman method on GTEx
whole-blood data using the GEPIA portal [29]. At single cell level, a
normalized single-cell matrix for 63628 peripheral blood mononu-
clear cells (PBMC) from a healthy donor were obtained from the web-
site http://tisch.comp-genomics.org/gallery/. Feature counts for each
cell were normalized by ‘LogNormalize’, a global-scaling method that
normalizes the cellular feature expression by dividing the total
counts for that cell using R package Seurat (https://satijalab.org/
seurat/), multiplied that by a scale factor (10000 by default), followed
by a natural-log transformation. Spearman's correlation between
mRNA levels of target genes was calculated using cells where normal-
ized expression levels of both genes was larger than zero.
2.3.6. Phenome-wide association test for DNA methylation sites
regulated by modifiable POE
We collected 79 phenotypes measured in GS:SFHS (recorded data-
set and linked health records) to identify phenotypes correlated with
DNA methylation levels at CpG sites targeted by modifiable POE. The
full list of phenotypes tested can be found in Table s7. The correlation
was tested by regressing the adjusted M-values of methylation sites
on each phenotype variable. Covariates included age, age2, cell pro-
portion, sex, top 20 ORM-PCs and smoking variables (‘pack years’ and
‘lifetime smoking status’; these were not included as covariates when
they were the tested phenotype). The test was performed in the dis-
covery and replication samples separately and meta-analyzed using a
random effect model using the R package metafor [30]. The sample
size varied depending on the number of missing samples for each
specific phenotype (Table s8). The Bonferroni method was used for
multiple testing correction (Ncorrection=79*3=237).
2.4. Access to data
Summary statistics supporting the conclusions of this article are
included within the article and its additional files. GS:SFHS: the Gen-
eration Scotland data used here are available from the MRC IGC Insti-
tutional Data Access / Ethics Committee for researchers who meet
the criteria for access to confidential data. Applications should be
submitted to the Generation Scotland Access Committee (access@ge-



































































































































































































































































































































































































































































































































































































































































































































































































































































































6 Y. Zeng et al. / EBioMedicine 74 (2021) 103730approval is granted only to research which comes under the terms of
participant consent which does not allow making participant infor-
mation publicly available. ORCARDES: there is neither research ethics
committee approval, nor consent from individual participants, to per-
mit open release of the individual level research data underlying this
study. Please contact the QTL Data Access Committee (accessQTL@ed.
ac.uk) for further information if required.
2.5. Role of funders
The Funders had no role in the study design; the collection, the
analysis, the interpretation of the data, and the writing of the paper.
3. Results
3.1. DNA methylation sites targeted by modifiable POE
In GS:SFHS, 2315 participants have both parent-of-origin phased
genotypes and DNA methylation data available. DNA methylation
levels were obtained in two batches, for 1663 participants in the first
batch in 2016 and for 652 in the second batch in 2019. These were
used as the discovery and the replication datasets respectively. Par-
ticipants in the discovery dataset were genetically independent from
participants in the replication dataset (relatedness < 0.05). The two
datasets have similar distribution for age: 34.5(18-56) in discovery
set vs 34.2(18-58) in replication set (P=0.61, t-test) and gender:
female:male: 62%: 38% in discovery set and 58%: 42% in replication
set (P=0.08, Chi-squared test).
We utilized information on 75 environmental and 26 genetic vari-
ables to test if any of them significantly modified the parent-of-origin
effects of the mQTLs on methylation level of the targeted CpGs, alter-
ing the methylation difference between reciprocal heterozygotes of
the mQTLs (Figure 1). The environmental candidate modifiers
reflected the environments/events the participants have been
exposed to or have experienced, including those measuring baseline
non-genetic effects (sex, age), medication, lifestyle, socioeconomic
status, birth-related phenotypes (measured before or after partici-
pants’ birth) and menarche/menopause-related events; the genetic
candidate modifiers were genetic factors known to be involved in
DNA methylation and imprinting processes, including ‘predicted
whole blood mRNA expression levels’ of DNA methylation- or
imprinting-specific machinery genes, and PRSs for folate-related
metabolism (details in Methods and Table s1).
POE-mQTL-modifier models were applied to identify modifiable
POE on DNA methylation, with age, sex, cell proportions, smoking
variables (‘pack years’ and ‘lifetime smoking status’, which were not
included as covariates when they were the tested modifier factor)
and ORM PCs (see Methods) fitted as covariates. At the discovery
stage, a global permutation test was combined with mQTL-modifier-
CpG trio-specific permutation tests (Text s3) to determine mQTL-
modifier-CpG trios for significant POEmQTL x Modifier interaction effect
on DNA methylation (see Methods). At the replication stage, a suc-
cessful replication required both statistical significance and pattern
consistency (direction-of-effect) for both the main POE and the
POEmQTL x Modifier interaction effect in tested mQTL-modifier-CpG
trios.
In total, four mQTL-modifier-CpG trios reached significance in the
discovery sample (Pglobal(FDR_adjusted) < 0.05, Ptrio-specific(Bonferroni_adjusted)
< 0.05, permutation) and were successfully validated in the replica-
tion sample (Table 1, Text s2, Tables s4-6). Sensitivity analysis remov-
ing ORM PCs from the model obtained consistent results (Table s9).
These four mQTL-modifier-CpG trios involved one environmental
modifier: ‘lifetime smoking status’; and three genetic modifiers: ‘pre-
dicted mRNA expression levels’ of SIRT1 (a gene that protects methyl-
ation at imprinted loci by directly regulating acetylation of DNMT3L
[12,31]), TET2 (a DNA demethylation gene [12,32]) and KDM1A (a
Figure 3. CpGs regulated by the modifiable-POE. a. Proportion of methylation variation explained by different models for the three CpGs regulated by modifiable-POE. The ‘Base
model’ accounted for age, sex, cell proportion, smoking variables (‘pack years’ and ‘lifetime smoking status’. These were not included as covariates when they were the tested modi-
fier factor) and principal components of the OMIC (DNA methylation)-relationship-matrix. Mod: modifier; Add: additive genetic effect, Dom: dominance genetic effect. Add x Mod:
interaction between additive genetic effect and the modifier; POE x Mod: interaction between parent-of-origin genetic effect and the modifier. b. Distributions of methylation levels
of CpGs regulated by modifiable POE (NCpG=3), CpGs regulated by POE from known mQTLs but the POE is not modifiable (NCpG=583), CpGs regulated by POE but without an mQTL
identified (the CpGs were reported in ref 4: Zeng et al. (2019), NCpG=398) and randomly selected non-POE CpGs from all QCed array probes (NCpG=10,000). Unrelated individuals
from the GS:SFHS discovery subset were used to produce the plot.
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imprinted genes[12,33]). The three CpGs, cg18035618, cg21252175,
and cg22592140 were the methylation sites affected by these modifi-
cation effects (Table 1), with the POEmQTL x Modifier interaction effect
explaining between 1.0% to 2.2% of their methylation variation
(Figure 3a, Table s3). These CpGs displayed intermediate methylation
levels, when compared with the less-peaked distribution of methyla-
tion levels of POE-regulated CpGs not influenced by modifiable
effects, or the bimodally distributed methylation level of genomic
CpGs not influenced by POE (Figure 3b). Genomic annotation of the
three CpGs was displayed in Figure s1 and Table s10. Two of the three
CpGs (cg18035618 and cg22592140) were located within parent-of-
origin differentially methylated regions [34] and imprinting control
region (ICR) of imprinted genes GNAS and MEST [35], within 500bp
distance of the Fantom5 CAGE peaks for promoters [36], and over-
lapped with H3k4me1 and H3k4me3 histone modification regions
[37]. The third CpG (cg21252175) was located within CCCTC-binding
factor (CTCF) binding site, H3k4me and H3k27ac histone modification
regions [37].
To test 1) whether the three CpGs identified represent hotspot
DNA methylation regions for being regulated by the modifiable POE
(hopspot CpGs: CpGs with higher chance to be targeted by modifiable
POE than other CpGs), and 2) whether the four modifiers identified
represent hotspot factors to introduce the modification effect (hot-
spot factors: modifiers with higher chance to modify POE than other
potential modifiers), we ranked all mQTL-modifier-CpG trios includ-
ing those not reaching the significance threshold by P values of the
POEmQTL x Mod interaction. We found that the POEmQTL x Mod interac-
tions targeting the three modifiable-POE-regulated CpGs ranked sig-
nificantly higher than interactions targeting POE-CpGs with known
mQTLs but not influenced by modifiable POE (P< 2.2 £ 1016, Mann-
Whitney U test). On the other hand, among the three significant
genetic modifiers, POEmQTL x Mod interactions involving two of them,
‘predicted mRNA expression levels’ of TET2 and SIRT1, rankedsignificantly higher than interactions involving other tested modifiers
(PTET2 =1.62 £ 1012, PSIRT1 =6.22 £ 1015, Mann-Whitney U test). A
combined collection of smoking-related modifiers also displayed sig-
nificant enrichment for POEmQTL x Mod interactions although lifetime
smoking status itself along didn't display the enrichment (Psmoking-
related =2.49 £ 109, Plifetime_smoking_status =1, Mann-Whitney U test).
Thus, the three CpGs represented hotspots as the targets of POEmQTL x
Mod interaction effects, modifiers such as smoking-related modifiers
and ‘predicted mRNA expression levels’ of TET2 and SIRT1 repre-
sented important sources of modification effects with which more
modification effects can potentially be detected in better powered
future studies.
One of the three CpGs, cg18035618, was simultaneously targeted
by both environmental and genetic modification effects (Table 1).
cg18035618 (hg19: chromosome 20: 57415978) is located in the
gene GNAS (Figure 4). The methylation level of cg18035618 was sig-
nificantly modulated by a POEmQTL x Modifier interaction between its
mQTL, rs117020124, and ‘lifetime smoking status’ (Pdis=9.94 £ 107,
Prep=1.42 £ 103, t-test, Figure 4, Table 1), with current smokers dis-
playing larger contrast in methylation levels of cg18035618 between
heterozygous groups of the mQTL when compared with ex-smokers
and never-smokers (Figure 5a). For this CpG a significant POEmQTL x
Modifier interaction was also detected between another independent
mQTL, rs117823351, and ‘predicted mRNA expression levels of SIRT1’
(Pdis=3.68 £ 1010, Prep=1.01 £ 103, t-test, Figure 4, Table 1. SIRT1 is
located in chromosome 10), with lower SIRT1 expression correspond-
ing to an increased contrast of methylation levels between heterozy-
gous groups of the mQTL (Figure 5b). To rule out the possibility that
the sharing of the methylation target (cg18035618) by both genetic
and environmental modifiers was due to genetically influenced envi-
ronmental effects (i.e., SIRT1 expression influences smoking status)
[38], we calculated the correlation between ‘lifetime smoking status’
and ‘predicted mRNA expression levels of SIRT1’ and found no signifi-
cant correlation (R=0, P=0.968, Pearson).
Figure 4. Regional plot of the modifiable-POE affecting cg18035618 and nearby CpGs within a 20kb distance. Top two panels: upper - interaction effect between the POE of
cg18035618’s mQTL rs117823351 and ‘predicted mRNA expression levels of SIRT1’, bottom - interaction effect between the POE of cg18035618’s mQTL rs117020124 and ‘lifetime
smoking status’; log10 (P-value): minus log10 P-value (t test) of the POEmQTL x Modifier interaction effect; Dots show nearby measured CpGs located within a 20kb distance from
cg18035618, filling colour represents the correlation of methylation levels with cg18035618: red: positive correlation; blue:negative correlation; white: no significant correlation.
Middle panel: genes located within the 40kb genomic region. Bottom panel: correlation matrix between CpGs.
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3’ UTR region of gene ZNF609 (Figure s2a). For this CpG, a significant
POEmQTL x Modifier interaction was detected between the mQTL
rs111834387 and ‘predicted mRNA expression levels of TET2’
(Pdis=1.54 £ 106, Prep=7.76 £ 1011, t-test. TET2 is located in chromo-
some 4), with lower expression of TET2 reducing the contrast in
methylation levels of cg21252175 between heterozygous groups of
the mQTL (Table 1, Figure s3a). cg22592140, a CpG located in gene
MEST (Figure s2b), was significantly regulated by a POEmQTL x Modifier
interaction between its mQTL rs142053217 and ‘predicted mRNA
expression levels of KDM1A’ (Pdis=1.35 £ 106, Prep=6.09 £ 104, t-
test. KDM1A is located in chromosome 1), with lower expression of
KDM1A increasing the contrast in methylation levels of cg22592140
between heterozygous groups of the mQTL (Table 1, Figure s3b).
3.2. Localization of regulatory SNPs contributing to the genetic
modification effect
Considering that the three identified genetic modifiers (‘predicted
mRNA expression levels’ of SIRT1, TET2, KDM1A) are essentiallyweighted combinations of allelic scores at multiple regulatory SNPs,
we next tested whether the genetically driven modification effects
we detected here can be recapitulated by the POEmQTL x SNP interac-
tions between mQTLs and the SNPs used to derive the significant
genetic modifiers. Since ‘predicted mRNA expression’ of SIRT1,
KDM1A and TET2 was derived from two, one and two SNPs respec-
tively by the MASHR method in PrediXcan (see Methods) [39], we
tested POEmQTL x SNP interactions for those 5 SNPs (Ntest=5). We iden-
tified four of the five SNPs significantly interacting with the POEmQTL,
that is, regulating the CpGs where the interaction effect was initially
detected (Table 2, Figure 6). For example, for cg18035618 we
detected a significant interaction effect (Pdis=3.69 £ 109,
Prep=4.33 £ 103, t-test) between rs932658, a SNP used in the predic-
tion model for SIRT1 expression, and rs117823351, the mQTL that sig-
nificantly interacted with ‘predicted mRNA expression levels of
SIRT1’. When accounting for these significant POEmQTL x SNP interac-
tion effects as conditional items in the interaction model for the three
genetic-modifiers, the interaction effects at the genetic-modifier-
level (POEmQTL x ModifierGenetic) were reduced to a non-significant
level, suggesting the leading role of POEmQTL x SNP underlying the
Figure 5. Both environmental and genetic factors significantly modified the POE of mQTLs on cg18036618. a). top:cg18036618 was regulated by the POE of the mQTL rs117020124.
bottom: the POE of rs117020124 was modified by lifetime smoking status. The contrast in methylation levels of cg18035618 between heterozygotes of the mQTL rs117020124 is
largest in current smoker group. b). top:cg18036618 was regulated by the POE of the mQTL rs117823351. bottom: the POE of rs117823351 was modified by ‘predicted mRNA
expression level of SIRT1’. The contrast in methylation levels of cg18035618 between heterozygotes of the mQTL rs117823351 is larger in individuals with low SIRT1 expression.
High/low expression: participants with predicted expression levels larger than the median were categorized as the high group.
Y. Zeng et al. / EBioMedicine 74 (2021) 103730 9significant interaction effect from genetic modifiers we detected here
(Table s12).
3.3. Proteins associated with modifiable-POE-regulated methylation sites
Having identified CpGs regulated by the modifiable POE, we next
examined if any health-related phenotypic variation can be linked to
methylation variations of the CpGs in this class. Plasma protein levelsare molecular phenotypes which are closer to the methylation layer
as compared to higher layer complex phenotypes such as diseases
and behavior traits. Thus, CpG-protein association analysis could pro-
vide important insights of functional variation associated with modi-
fiable-POE-regulated CpGs. The ORCADES cohort simultaneously
obtained plasma levels of 1092 proteins measured by the Olink
Proseek multiplex panel and genome-wide DNA methylation data
(Nsample =940), which allowed the identification of proteins
Table 2
SNPs that significantly interact with POE (POEmQTL x SNP) and the regulated CpGs
mQTL-CpG SNP modifier Discovery Replication
CpG: id mQTL: id SNP id Relation to G modifier P(dis, t-test) Adjust_P(dis,t-test) Est(dis) N(dis) P(rep,t-test) Est(rep) N(rep)
cg22592140 rs142053217 rs75667410_T SNP used in predict KDM1A exp 1.35E-06 6.75E-06 0.18 1607 6.09E-04 0.18 645
cg21252175 rs111834387 rs11729069_G SNP used in predicting TET2 exp 1.05E-08 5.25E-08 0.18 1607 Not enough data*
rs7661349_T 3.51E-02 1.76E-01 -0.06 1607 Not significant in Discovery sample
cg18035618 rs117823351 rs932658_A SNP used in predict SIRT1 exp 3.69E-09 1.85E-08 -0.07 1607 4.33E-03 -0.06 646
rs3740053_G 1.55E-04 7.75E-04 -1.00E-01 1607 6.01E-03 -0.10 646
dis: discovery sample, rep: replication sample. N: sample size. P(dis, t-test)/P(rep, t-test) and Est(dis)/Est(rep): P values (t-test) and coefficients for the POEmQTL x SNP interaction in
the interaction model in discovery/replication samples. Adjust_P(dis, t-test): Bonferroni method adjusted P(dis, t-test). *, due to the relatively small minor allele frequency (MAF)
of rs111834387(MAF=0.01) and the limited sample size of replication sample, there was not enough data for this test in replication samples. Number of individuals within hetero-
zygous groups available for testing POE(rs111834387) x SNP(rs11729069) interaction effect on cg21252175 in replication samples were shown in Table s11.
Figure 6. The three modifiable-POE-targeted CpGs were also significantly regulated by POEmQTL x SNP interaction effects between the mQTLs and the SNPs used to drive the genetic
modifiers. The contrast in methylation levels of the candidate CpGs in mQTL heterozygotes varied depending on the allelic dosage of the SNP used to derive the corresponding
genetic modifier. *due to the limitation of sample size, minor homozygous/heterozygous genotype groups were missing in some tests.
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1092 proteins assayed by the Olink panels applied are already func-
tionally important  they are proteins relevant to diseases andbiological process (cardiometabolism, immune response, neurology
etc.). The results showed only one CpG-protein pair passed Bonfer-
roni-based multiple testing correction (Ntest=3,276, full results in
Y. Zeng et al. / EBioMedicine 74 (2021) 103730 11Table s13): cg21252175 was significantly associated (in trans) with
plasma protein level of CLEC4C, a protein from the Olink immune-
response panel (Beta=0.049, Padj=0.002, t-test).
Since cg21252175 is located in the UTR3 of gene ZNF609, we fur-
ther examined whether the association between cg21252175 and
CLEC4C protein levels implied a link between ZNF609 and CLEC4C.
Using data from MESA study [28], a significant and positive correla-
tion was detected between methylation levels of cg2125217 and
mRNA levels of ZNF609 in both CD4+ peripheral T cells (R=0.15,
P=0.03, Spearman) and CD14+ peripheral monocytes (R=0.15,
P=1.52 £ 106, Spearman, Figure s4a). Using whole blood data from
the GTEx consortium through the GEPIA portal [29,40], mRNA
expression level of ZNF609 was significantly correlated with mRNA
expression levels of CLEC4C at population level (R=0.21, P=1.1 £ 104,
Spearman, Figure s4b). Using a single-cell RNA-seq data of PBMC in
an adult donor, mRNA expression levels of ZNF609 and CLEC4C were
significantly correlated at individual level (R=0.36, P=0.0002, Spear-
man, Figure s4c).
3.4. Phenotypes associated with modifiable-POE-regulated methylation
sites
To explore the association between variation in CpGs targeted by
modifiable POE and health/disease-related phenotypes, we collected
79 phenotypes in GS:SFHS (Table s7). Phenome-wide association
tests relating methylation levels to phenotypes were performed for
the three identified modifiable-POE-regulated CpGs using the whole
GS:SFHS methylation sample (meta-analyzed across discovery (Nsam-
ple=5081) and replication (Nsample=4445) samples; total Nsam-
ple=9526.). After Bonferroni-based multiple testing correction
(Ntest=79 £ 3=237), two CpG-phenotype associations reached phe-
nome-wide significance: cg21252175 was both associated with ‘life-
time smoking status’ (Padj= 9.0 £ 105, t-test) and high-density
lipoprotein (HDL) levels (Padj =0.006, t-test) (Figure 7, Table s8).Figure 7. Forest plot for phenotypes associated with cg21252175. HDL: high-densiAlthough limited by sample size (Figure 7), cg21252175 was also
associated with gestational age (measured as weeks at birth) at an
adjusted P  0.06 level (Padj=0.056, t-test). These associations dis-
played consistent patterns across discovery and replication samples
(Figure 7, Table s8).
4. Discussion
In this study, we reported significant and replicated modification
effects from both genetic and environmental variables on the parent-
of-origin effect that affects DNA methylation levels at three CpGs.
Identified environmental modifiers included ‘lifetime smoking sta-
tus’; genetic modifiers included ‘predicted mRNA expression levels’
of several DNA methylation/imprinting machinery genes (SIRT1,
TET2, KDM1A). Importantly, we found that both genetic and environ-
mental modifiers were targeting the same CpG (cg18035618). These
provided evidence for a special type of CpGs in the human genome
regulated by parent-of-origin-effects that are modulated by genetic
or environmental modifiers. We further found that these CpGs are
likely to be phenotypically relevant: for molecular phenotypes, DNA
methylation level at one the CpG, cg21252175, was associated with
protein levels of the immune-response-related protein CLEC4C. For
non-molecular phenotypes, this CpG was associated with ‘lifetime
smoking status’, HDL levels and gestational age(the latter at the sug-
gestive significance level).
Statistically, the model we proposed here for detecting modifiable
POE is built on a previous POE-mQTL model which we used to localize
regulatory mQTLs for the POE-influenced CpGs (model 1 in Methods)
[4,24]. For those CpGs, one of the hallmarks of the POE-regulation
was the methylation difference between the two heterozygous mQTL
genotype groups (Figure 1) [4,6]. Here, our new interaction model
tests whether that difference remains stable or varies under certain
conditions, that is, if the parent-of-origin effects are the same or dif-
ferent across different environments or in different geneticty lipoprotein. Meta: Meta-analysis performed using the random effect model.
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ferent layer of regulation for DNA methylation: genetic/environmen-
tal factors could influence the level of DNA methylation of CpGs, not
only through direct effects, but also through interacting with the POE
(Figure 1).
Our results support this hypothesis. Smoking has been widely
studied for its direct influence on DNA methylation [41,42] and its
interactions with additive genetic effects on methylation levels [43].
Here, for the first time, our study reported that smoking could also
affect DNA methylation variation indirectly through interaction with
a non-additive genetic effect, POE. Similarly, variation in DNA meth-
ylation and imprinting machinery genes, either in the forms of vari-
able expression or mutation, have been known to directly affect DNA
methylation. SIRT1 regulates DNA methylation and protects methyla-
tion at imprinted loci by directly regulating acetylation of DNMT3L,
which is required for the establishment of maternal genomic
imprints [12,31]. TET2 promotes DNA demethylation by converting
5-methyl-cytosine to 5-hydroxymethyl-cytosine and is required for
demethylation at imprinted loci in the germline [12,32]. KDM1A
removes methylation of histone H3K4 in imprinted genes, its defi-
ciency is associated with alterations in DNA methylation and expres-
sion at imprinted genes [12,33]. Here, our results provided human-
study evidence in vivo for the role of these machinery genes in POE-
related methylation variation. Importantly, for the first time we
showed that besides direct effects, these genetic factors could intro-
duce indirect regulatory effects on DNA methylation levels through
interactions with POE.
The detection of interactions between genetic modifiers and POE
led us to further identify significant and replicated POEmQTL x SNP
interaction effects between mQTLs and SNPs used in imputing
genetic modifiers. One important feature of the genetic modifier vari-
ables we derived here is that they represent the proportion of mRNA
variation determined by germline genetic variation, which is con-
stant and stable throughout the life [39]. Our results demonstrated
that an individual’s genetic background of DNA methylation and
imprinting machineries has the potential to modify POE. The localiza-
tion of the genetic-based modification effect at regulatory SNPs of
these DNA methylation and imprinting machinery genes strongly
supports this, and importantly, indicated that genetic variation in
machinery genes is an important source of epistasis. One of the
machinery genes, SIRT1, has been well known for its role in mental
health disorders such as depression [44], but very few studies have
examined its role as a modifier for non-additive genetic effect such as
POE. Our result revealed a new potential path of variation in this
gene to introduce molecular differences.
The reason why POE can be modified is deeply rooted in the
unique nature of genomic imprinting: established at an early devel-
opmental stage, needing to be protected from global-demethylation
and maintained throughout the lifespan [12]. These complex and
multi-stage processes have been shown to be vulnerable to environ-
mental fluctuations and involve delicate regulation of multiple
gametic and zygotic genetic factors, including TET2, SIRT1, KDM1A as
we identified here [11,12]. Indeed, the vulnerability of at least a sub-
set of POE-CpGs was revealed here, as the POEmQTL x Modifier interac-
tion effect explained a non-negligible proportion of methylation
variance (1%-2.2%), and that at least one (cg18035618) of the three
CpGs identified was targeted by independent environmental and
genetic modifiers. The detection of modifiable POE on cg22592140, a
CpG located in MEST was in line with a previous study suggesting the
methylation status in the MEST region is vulnerable to perturbations
as compared to other imprinted regions, likely due to its later meth-
ylation acquisition kinetics [45]. The third modifiable-POE influenced
CpG, cg21252175, was associated with CLEC4C, an immune-response
transmembrane protein treated as a marker gene for plasmacytoid
dendritic cells [46]. This CpG was also associated with ‘lifetime smok-
ing status’, HDL levels and gestational age (the latter at the suggestivesignificance level) (Figure 7) in our analysis, and was previously
found to be associated with maternal body mass index/overweight/
obesity [47]. These convergent lines indicated that this newly uncov-
ered class of vulnerable POE-CpGs may play an important role in con-
necting early life stress, variations in genetic background and later
life health issues.
The three modifiable-POE regulated CpGs are likely to be impor-
tant for the POE patterns in local regions. Two of the three CpGs were
located in ICR, the third CpG was located within CTCF binding site
(Figure s1). ICR are crucial control regions usually found to be respon-
sible for the POE patterns of large ranges of nearby regions [48],
regional regulatory mechanisms through ICRs have been constantly
linked to the binding of CTCF [12], and CTCF binding is influenced by
DNA methylation [49]. These facts, combined with that all three CpGs
display active epigenetic activity (overlap with H3k4me1, H3k4me3,
H3k27ac narrow peaks), may implicate the potential of regional
influences from the modification of POE through regulating modifi-
able CpGs in ICR regions.
Beyond the complexity of POE-regulation revealed here, our
observations that both a person’s genetic and environmental back-
ground can modify how a POE-mQTL regulates its target CpG demon-
strates an important general principle for medical genetic research
and relevant clinical applications which is that it can be important to
account for the environmental context and the genetic background.
DNA methylation has been proposed as promising regulatory target
for pharmaceutical interventions [50], but for any clinical application
relating to CpGs subjected to modification effects, it would be neces-
sary to consider both genotype and environmental exposures when
tailoring any intervention. Taking cg18035618, its mQTL
rs117020124 and the modifier “lifetime smoking status” as an exam-
ple, if we do not account for lifetime smoking status, carriers of the
AG genotype (that should be distinguished from the GA genotype) of
the mQTL rs117020124 displayed lower methylation levels for
cg18035618 when compared to non-carriers; when accounting for
lifetime smoking status, we found AG genotypes carriers could be fur-
ther stratified and that carriers who are also current smokers display
the lowest methylation level of the CpG (Figure 5a).
There are limitations in this study. First, mRNA expression levels
used here were predicted and only reflect genetically influenced
expression variation (and not necessarily all of it). Future studies
examining measured mRNA expression will be necessary to account
for the modification effect from the environmentally determined
fraction of mRNA expression. Second, the analyses performed here
simultaneously require DNA methylation data and SNP data with
information of parent-of-origin of the alleles transmitted to the off-
spring. Our sample size was relatively limited in size, only focuses on
CpGs which previously were found to show parent of origin effects
and is only based on DNA from one tissue (blood) and in individuals
who were relatively young (mean age = 34). Thus we may well
underestimate the scale of interactions with environmental effects or
the genetic background that affect DNA methylation. Further work
would benefit from larger sample sizes from multiple tissues and
across a wide range of ages as well as further validation in other
cohorts. Finally, the exact time window or developmental stage in
which each environmental modifier exerted their influences remains
unknown. Cohort data with higher resolution of environmental expo-
sure records, in particular those measuring early life exposures, will
be crucial to understand the vulnerable stage or stages for CpGs influ-
enced by modifiable POE.
In conclusion, we provided population-level evidence for modifi-
cation effects from multiple genetic and environmental factors on
parent-of-origin-effects at the DNA methylation level. A subset of
parent-of-origin-effect-influenced CpGs that are vulnerable to modi-
fication effects were uncovered, which opens new questions for
future profiling of the modification patterns and phenotypic conse-
quences of this class of CpGs.
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